Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon
Antiviral Therapy · 2017-02 · 22 (2) · 179-184
DOI: 10.3851/imp3165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antiviral Therapy, online erschienen am 01.02.2017. Verfasst von Catherine A Hankins und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The underpinning theme of the 2016 INTEREST Conference held in Yaoundé, Cameroon, 3–6 May 2016 was ending AIDS as a public health threat by 2030. Focused primarily on HIV treatment, pathogenesis and prevention research in resource-limited settings, the conference attracted 369 active delegates from 34 countries, of which 22 were in Africa. Presentations on treatment optimization, acquired drug resistance, care of children and adolescents, laboratory monitoring and diagnostics, implementation challenges, HIV prevention, key populations, vaccine and cure, hepatitis C, mHealth, financing the HIV response and emerging pathogens, were accompanied by oral, mini-oral and poster presentations. Spirited plenary debates on the UNAIDS 90-90-90 treatment cascade goal and on antiretroviral pre-exposure prophylaxis took place. Joep Lange career guidance sessions and grantspersonship sessions attracted early career researchers. At the closing ceremony, the Yaoundé Declaration called on African governments; UNAIDS; development, bilateral, and multilateral partners; and civil society to adopt urgent and sustained approaches to end HIV by 2030.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands.
- London School of Hygiene and Tropical Medicine, London, UK.
- Ministry of Health, Yaoundé, Cameroon.
- National Institutes of Health, Fogarty International Center, Bethesda, MD, USA.
- Duke University Medical Center, Department of Surgery, Durham, NC, USA.
- Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Förderung
- NIAID NIH HHS
Zitieren
APA
Hankins, C. A., Koulla-Shiro, S., Kilmarx, P., Ferrari, G., Schechter, M., Kane, C. T., Venter, F., Boucher, C. A., Ross, A. L., Zewdie, D., Eholié, S. P., & Katabira, E. (2017). Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon. Antiviral Therapy, 22(2), 179-184. https://doi.org/10.3851/imp3165
Vancouver
Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, et al. Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon. Antiviral Therapy. 2017;22(2):179-184. doi:10.3851/imp3165
BibTeX
@article{Hankins2017,
author = {Hankins, Catherine A and Koulla-Shiro, Sinata and Kilmarx, Peter and Ferrari, Guido and Schechter, Mauro and Kane, Coumba Touré and Venter, François and Boucher, Charles Ab and Ross, Anna-Laura and Zewdie, Debrework and Eholié, Serge Paul and Katabira, Elly},
title = {Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon},
journal = {Antiviral Therapy},
year = {2017},
volume = {22},
number = {2},
pages = {179--184},
doi = {10.3851/imp3165}
}
EUVIMED